Trade Enovis Corporation - ENOV CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.17 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 42.94 |
| Open | 42.76 |
| 1-Year Change | -20.83% |
| Day's Range | 42.59 - 43.16 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 9, 2024 | 42.94 | 0.08 | 0.19% | 42.86 | 44.42 | 42.21 |
| Sep 6, 2024 | 43.40 | 0.57 | 1.33% | 42.83 | 44.30 | 42.71 |
| Sep 5, 2024 | 43.06 | -0.98 | -2.23% | 44.04 | 44.04 | 43.05 |
| Sep 4, 2024 | 44.16 | -0.01 | -0.02% | 44.17 | 44.60 | 43.84 |
| Sep 3, 2024 | 44.49 | -1.34 | -2.92% | 45.83 | 46.59 | 44.23 |
| Aug 30, 2024 | 46.54 | 0.83 | 1.82% | 45.71 | 46.61 | 45.52 |
| Aug 29, 2024 | 45.94 | 0.63 | 1.39% | 45.31 | 46.47 | 44.95 |
| Aug 28, 2024 | 45.25 | 0.96 | 2.17% | 44.29 | 45.88 | 44.29 |
| Aug 27, 2024 | 45.44 | 0.59 | 1.32% | 44.85 | 45.71 | 44.75 |
| Aug 26, 2024 | 45.65 | -0.04 | -0.09% | 45.69 | 46.49 | 45.49 |
| Aug 23, 2024 | 45.97 | 2.49 | 5.73% | 43.48 | 46.07 | 43.48 |
| Aug 22, 2024 | 44.02 | 0.06 | 0.14% | 43.96 | 44.63 | 43.77 |
| Aug 21, 2024 | 44.30 | 0.27 | 0.61% | 44.03 | 44.56 | 43.59 |
| Aug 20, 2024 | 44.19 | -0.09 | -0.20% | 44.28 | 44.44 | 44.01 |
| Aug 19, 2024 | 44.66 | 0.58 | 1.32% | 44.08 | 44.75 | 44.07 |
| Aug 16, 2024 | 44.10 | 0.66 | 1.52% | 43.44 | 44.65 | 43.44 |
| Aug 15, 2024 | 44.38 | 1.45 | 3.38% | 42.93 | 44.58 | 42.93 |
| Aug 14, 2024 | 42.94 | -0.20 | -0.46% | 43.14 | 43.49 | 42.66 |
| Aug 13, 2024 | 43.19 | 1.24 | 2.96% | 41.95 | 43.58 | 41.95 |
| Aug 12, 2024 | 42.31 | -0.63 | -1.47% | 42.94 | 43.15 | 42.27 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Enovis Corporation Company profile
About Colfax Corp
Colfax Corporation is a technology company that provides orthopedic care and fabrication technology products and services. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Colfax Corp revenues increased 26% to $3.85B. Net income before extraordinary items increased 74% to $94.1M. Revenues reflect Fabrication technology segment increase of 25% to $2.43B, Medical Technology segment increase of 27% to $1.43B, Other Foreign locations segment increase of 28% to $2.29B, United States segment increase of 22% to $1.56B.
Equity composition
Common Stock $.001 Par, 07/11, 200M auth., 43,570,561 issd. Insiders own approx. 25.62%. 5/8/08, 18.8M shares @ $18byMerrill Lynch & Co., Lehman Brothers and UBS Investment Bank.
| Industry: | Medical Devices & Implants |
2711 Centerville Road
Suite 400
WILMINGTON
DELAWARE 19808
US
News
Market analysis: US CPI and PPI
Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.
07:56, 10 September 2024
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024
FOMC PREVIEW
Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.
14:09, 1 August 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com